Evidence behind the WHO guidelines: Hospital care for children: What is the evidence that BCG vaccination should not be used in HIV-infected children?

Journal of Tropical Pediatrics

Volumn 55, Issue 2, 2009, Pages 78-82

  Bannister, Charmian ^a   Bennett, Laura ^a   Carville, Aisling ^a   Azzopardi, Peter ^b  

^a SWANSEA UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; BCG VACCINE;

BCG VACCINATION; CHILD; CHILD HEALTH CARE; DRUG CONTRAINDICATION; DRUG EFFICACY; EVIDENCE BASED MEDICINE; HIGH RISK POPULATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOSPITAL CARE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; INJECTION SITE ABSCESS; LYMPHADENITIS; LYMPHADENOPATHY; PRACTICE GUIDELINE; REVIEW; RISK BENEFIT ANALYSIS; SUPPURATION; TUBERCULOSIS; WORLD HEALTH ORGANIZATION;

BCG VACCINE; CHILD; CHILD, PRESCHOOL; EVIDENCE-BASED MEDICINE; HIV INFECTIONS; HIV-1; HOSPITALIZATION; HUMANS; PRACTICE GUIDELINES AS TOPIC; RISK FACTORS; TUBERCULOSIS; WORLD HEALTH ORGANIZATION;

EID: 63849128175     PISSN: 01426338     EISSN: 14653664     Source Type: Journal    
DOI: 10.1093/tropej/fmp018     Document Type: Review

References (22)

1. Hussey G, Hawkridge T, Hanekom H. Childhood tuberculosis: Old and new vaccines. Paediatr Respir Rev 2007;8:148-54.
2. Trunz BB, Fine P, Dye C. Effect of BCG vaccination on childhood tuberculous meningitis and military tuberculosis worldwide: A meta-analysis and assessment of cost-effectiveness. Lancet 2006;367:1173-80.
3. Fordham von Reyn C. Routine childhood Bacille Calmette Guerin immunization and HIV infection. Clin Infect Dis 2006;42:559-61.
4. Moss WJ, Clements CJ, Halsey NA. Immunization of children at risk of infection with human immunodeficiency virus. Bull World Health Organ 2003;81(1):61-70.
5. Nuttall J, Davies M, Hussey G, et al. Bacillus Calmette-Guerin (BCG) vaccine-induced complications in children treated with highly active antiretroviral therapy. Int J Infect Dis 2008;12:e99-105.
6. Hesseling A, Schaaf H, Hanekom W, et al. Danish Bacille Calmette-Guerin vaccine-induced disease in Human Immunodeficiency Virus-Infected children. Clin Infect Dis 2003;37:1226-33.
7. Enarson PM, Enarson DA, Gie R. Management of tuberculosis in children in low-income countries. Int J Tuberc Lung Dis 2005;9:1299-04.
8. Meeting of the immunization Strategic Advisory Group of Experts, April 2007 - conclusions and recommendations. No. 21, 2007, 82, 181-196 http://www.who.int/wer.
9. Hesseling A, Cotton M, Fordham von Reyn C, et al. Consensus statement on the revised World Health Organization recommendations for BCG vaccination in HIV-infected infants. Int J Tuberc Lung Dis 2008;12:1376-9.
10. Mandavilli A. When the vaccine causes disease. Nat Med 2007;13:274.
11. Enserink M. In the HIV era, an old TB vaccine causes new problems. Science 2007;16:1059.
12. Puthanakit T, Oberdorfer P, Ukarapol N, et al. Immune reconstitution syndrome from nontuberculous mycobacterial infection after initiation of antiretroviral therapy in children with HIV infection. Pediatr Infect Dis J 2006;25:645-8.
13. Fallo A, Torrado L, Sánchez A, et al. Delayed complications of Bacille Calmette-Guérin (BCG) vaccination in HIV-infected children. Presented at the International AIDS Society Meeting, 2005 www.ias-2005.org/planner/Presentations/ppt/749.ppt.
14. Archibald L, Kazembe P, Nwanyanwu O, et al. Epidemiology of bloodstream infections in a Bacille Calmette-Guerin-Vaccinated pediatric population in Malawi. J Infect Dis 2003;188:202-8.
15. Besnard M, Sauvion S, Offredo C, et al. Bacillus Calmette-Guerin infection after vaccination of human immunodeficiency virus-infected children. Pediatr Infect Dis J 1993;12:993-7.
16. O'Brien K, Ruff A, Louis M, et al. Bacillus Calmette-Guerin complications in children born to HIV-1-infected women with a review of the literature. Pediatrics 1995;95:414-18.
17. Chokephaibulkit K, Chotpitayasunondh T, Vanprapar N, et al. Assessment of bacille Calmette-Guérin vaccine reaction in HIV-exposed Thai infants. Clin Infect Dis 2007;45:1016-18.
18. Hesseling AC, Rabie H, Marais BJ, et al. Bacille Calmette-Guérin vaccine-induced disease in HIV-infected and HIV-uninfected children. Clin Infect Dis 2006;15;42:548-58.
19. Msellati P, Dabis F. BCG immunization and paediatric HIV infection. Wkly Epidemiol Rec 1992;67:129-32.
20. Hesseling AC, Marais B, Gie RP, et al. The risk of disseminated Bacille Calmette-Guerin (BCG) disease in HIV infected children. Vaccine 2007;25:14-18.
21. de Souza Campos Fernandes RC, de Araújo LC, Medina-Acosta E. Reduced rate of adverse reactions to the BCG vaccine in children exposed to the vertical transmission of HIV infection and in HIV-infected children from an endemic setting in Brazil. Eur J Pediatr 2008 Sep 3. [Epub ahead of print].
22. Waddell R, Lishimpi K, Fordham von Ryen C, Chintu C, et al. Bacteremia due to Mycobacterium tunerculosis or M. bovis, Bacille Calmette - Guerin (BCG) among HIV-positive children and adults in Zambia. AIDS 2001;15:55-60.